Anthony J. Hickey

11.4k total citations · 1 hit paper
288 papers, 8.2k citations indexed

About

Anthony J. Hickey is a scholar working on Pulmonary and Respiratory Medicine, Pharmaceutical Science and Epidemiology. According to data from OpenAlex, Anthony J. Hickey has authored 288 papers receiving a total of 8.2k indexed citations (citations by other indexed papers that have themselves been cited), including 191 papers in Pulmonary and Respiratory Medicine, 64 papers in Pharmaceutical Science and 49 papers in Epidemiology. Recurrent topics in Anthony J. Hickey's work include Inhalation and Respiratory Drug Delivery (187 papers), Drug Solubulity and Delivery Systems (45 papers) and Microencapsulation and Drying Processes (29 papers). Anthony J. Hickey is often cited by papers focused on Inhalation and Respiratory Drug Delivery (187 papers), Drug Solubulity and Delivery Systems (45 papers) and Microencapsulation and Drying Processes (29 papers). Anthony J. Hickey collaborates with scholars based in United States, United Kingdom and Ireland. Anthony J. Hickey's co-authors include M Telko, Lucila Garcia‐Contreras, Patrick J. O’Hara, Dongmei Lu, Ted B. Martonen, Heidi M. Mansour, Timothy M. Crowder, Hugh D. C. Smyth, David A. Edwards and Pavan Muttil and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Materials and SHILAP Revista de lepidopterología.

In The Last Decade

Anthony J. Hickey

277 papers receiving 7.9k citations

Hit Papers

Exploiting machine learning for end-to-end drug discovery... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anthony J. Hickey United States 49 5.2k 2.6k 1.5k 1.3k 1.0k 288 8.2k
Henderik W. Frijlink Netherlands 59 4.1k 0.8× 3.7k 1.4× 2.2k 1.5× 2.5k 1.9× 1.2k 1.2× 340 12.1k
David A. Edwards United States 45 3.7k 0.7× 2.3k 0.9× 1.2k 0.8× 903 0.7× 490 0.5× 184 9.1k
Paul M. Young Australia 49 4.7k 0.9× 2.4k 0.9× 1.6k 1.0× 1.1k 0.8× 334 0.3× 317 8.9k
Daniela Traini Australia 44 4.1k 0.8× 2.2k 0.8× 1.2k 0.8× 1.1k 0.8× 274 0.3× 278 6.8k
Robert O. Williams United States 59 2.8k 0.5× 6.9k 2.6× 2.1k 1.4× 2.5k 1.9× 322 0.3× 295 12.3k
Hugh D. C. Smyth United States 43 2.2k 0.4× 1.6k 0.6× 815 0.5× 1.3k 1.0× 204 0.2× 172 5.6k
Warren H. Finlay Canada 49 5.5k 1.1× 982 0.4× 997 0.7× 591 0.5× 255 0.3× 233 7.8k
Claus‐Michael Lehr Germany 81 4.1k 0.8× 8.9k 3.4× 1.6k 1.1× 6.1k 4.7× 856 0.8× 417 22.0k
Reinhard Vehring Canada 35 2.7k 0.5× 1.3k 0.5× 1.9k 1.3× 470 0.4× 184 0.2× 107 4.8k
Qi Zhou United States 41 2.1k 0.4× 1.3k 0.5× 1.1k 0.8× 903 0.7× 321 0.3× 149 4.9k

Countries citing papers authored by Anthony J. Hickey

Since Specialization
Citations

This map shows the geographic impact of Anthony J. Hickey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony J. Hickey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony J. Hickey more than expected).

Fields of papers citing papers by Anthony J. Hickey

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony J. Hickey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony J. Hickey. The network helps show where Anthony J. Hickey may publish in the future.

Co-authorship network of co-authors of Anthony J. Hickey

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony J. Hickey. A scholar is included among the top collaborators of Anthony J. Hickey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony J. Hickey. Anthony J. Hickey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hickey, Anthony J. & Stefano Giovagnoli. (2025). Pharmaceutical Powder and Particles. 1 indexed citations
2.
McSweeney, Morgan D., Alison Schaefer, Whitney Wolf, et al.. (2024). Inhaled “Muco‐Trapping” Monoclonal Antibody Effectively Treats Established Respiratory Syncytial Virus (RSV) Infections. Advanced Science. 11(12). e2306729–e2306729. 8 indexed citations
3.
Hickey, Anthony J., Sara E. Maloney, Philip J. Kuehl, Jonathan E. Phillips, & Ronald K. Wolff. (2024). Practical Considerations in Dose Extrapolation from Animals to Humans. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 37(2). 77–89. 3 indexed citations
4.
Dutt, Taru S., Amy L. MacNeill, H. Lam, et al.. (2024). A modified BPaL regimen for tuberculosis treatment replaces linezolid with inhaled spectinamides. eLife. 13. 1 indexed citations
5.
Hickey, Anthony J.. (2023). Dry Powder Inhalers: An Overview. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 36(6). 316–323. 11 indexed citations
6.
Maloney, Sara E., Ian E. Stewart, Brendan K. Podell, et al.. (2023). Preparation Strategies of the Anti-Mycobacterial Drug Bedaquiline for Intrapulmonary Routes of Administration. Pharmaceuticals. 16(5). 729–729. 6 indexed citations
7.
Aw, Wen Yih, Brian O. Diekman, Wesley R. Legant, et al.. (2023). Patient-derived extracellular matrix demonstrates role of COL3A1 in blood vessel mechanics. Acta Biomaterialia. 166. 346–359. 5 indexed citations
8.
Garcia‐Contreras, Lucila, et al.. (2021). Efficacy of Combined Rifampicin Formulations Delivered by the Pulmonary Route to Treat Tuberculosis in the Guinea Pig Model. Pharmaceutics. 13(8). 1309–1309. 9 indexed citations
9.
Schroeter, Jeffry D., Poonam Sheth, Anthony J. Hickey, et al.. (2018). Effects of Formulation Variables on Lung Dosimetry of Albuterol Sulfate Suspension and Beclomethasone Dipropionate Solution Metered Dose Inhalers. AAPS PharmSciTech. 19(5). 2335–2345. 10 indexed citations
10.
Hickey, Anthony J., et al.. (2018). Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs. International Journal of Pharmaceutics. 549(1-2). 306–316. 20 indexed citations
11.
Wood, Robin, Carl Morrow, Clifton E. Barry, et al.. (2016). Real-Time Investigation of Tuberculosis Transmission: Developing the Respiratory Aerosol Sampling Chamber (RASC). PLoS ONE. 11(1). e0146658–e0146658. 39 indexed citations
12.
13.
Muttil, Pavan, C. Prego, Lucila Garcia‐Contreras, et al.. (2010). Immunization of Guinea Pigs with Novel Hepatitis B Antigen as Nanoparticle Aggregate Powders Administered by the Pulmonary Route. The AAPS Journal. 12(3). 330–337. 44 indexed citations
14.
Weers, Jeffry G., John Bell, Hak‐Kim Chan, et al.. (2010). Pulmonary Formulations: What Remains to be Done?. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 23(S2). S–5. 91 indexed citations
15.
Hickey, Anthony J., Dongmei Lu, Elizabeth Dodds Ashley, & Jason E. Stout. (2006). Inhaled Azithromycin Therapy. Journal of Aerosol Medicine. 19(1). 54–60. 34 indexed citations
16.
Crowder, Timothy M., et al.. (2001). 2001: An Odyssey in Inhaler Formulation and Design. 25(7). 99–113. 21 indexed citations
17.
Hickey, Anthony J. & Craig Dunbar. (1997). A new millennium for inhaler technology. 21(6). 116–125. 18 indexed citations
18.
Hickey, Anthony J., et al.. (1996). Analysis of the patterns of particle dispersion from a dry powder inhaler. 20(6). 50–62. 3 indexed citations
19.
Schreier, Hans, et al.. (1993). Formulation and in vitro performance of liposome powder aerosols. 4(1). 38–44. 25 indexed citations
20.
Hickey, Anthony J., et al.. (1993). FACTORS INFLUENCING THE DISPERSION OF DRY POWDERS AS AEROSOLS. 18(8). 58–58. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026